Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency
NCT04594668Phase 2Unknown
- Sponsor
- Aarhus University
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
A Phase 2 trial of senicapoc in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Aarhus University. Status: unknown.
02
Drugs
senicapoc
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04594668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04594668.